文献速递气道管理

Spritztube气管插管与LMA Supreme在麻醉成人患者中的随机对照试验

Laryngeal Mask Airway Supreme vs. the Spritztube tracheal cannula in anaesthetised adult patients: A randomised controlled trial.
PubMed 文献 · Eur J Anaesthesiol · 2019-01-01

单中心随机对照试验纳入334例择期全麻仰卧位机械通气成人患者,比较Spritztube与LMA-S置入效果。LMA-S组9例置入失败而Spritztube组无失败(P=0.002),Spritztube置入容易率100%高于LMA-S的94.6%(P=0.03),LMA-S尝试次数更多(P=0.0007),置入时间相当(P=0.06),LMA-S血染发生率更高(P=0.01)。

要点

  • Spritztube置入成功率高于LMA-S,无置入失败病例。
  • Spritztube置入容易率100%,LMA-S为94.6%。
  • LMA-S尝试次数更多且血染发生率更高,置入时间两组相当。

核心结论

  • Spritztube维持气道有效性与LMA-S相当,所有患者均顺利通气。
  • 两组气道通畅成功率相当,并发症发生情况相似。

研究设计与样本

  • 单中心随机对照研究,三级医院开展。
  • 主要排除标准为根据SIAARTI指南存在或预测困难气道管理史及缺乏书面知情同意。

主要发现

  • LMA-S组9例置入失败,Spritztube组无失败(P=0.002)。
  • Spritztube置入容易率100%,LMA-S组94.6%(P=0.03)。
  • LMA-S尝试次数显著高于Spritztube(P=0.0007)。
  • 两组置入时间相当(P=0.06)。
  • LMA-S组血染发生率更高(P=0.01),其余并发症两组相当。

临床怎么用

  • 在择期全麻仰卧位成人患者中,Spritztube可作为LMA-S的替代声门上气道装置。
  • Spritztube置入失败率低且置入容易,可能减少反复尝试。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The Spritztube is a new supraglottic airway device combining the ability to allow extraglottic ventilation of the lungs with the opportunity to perform fibreoptic-assisted intubation. OBJECTIVES: To compare the Spritztube tracheal cannula with the Laryngeal Mask Airway Supreme (LMA-S) in anaesthetised adult patients. DESIGN: A single-centre, randomised controlled study. SETTING: Tertiary hospital. PATIENTS: Mechanically ventilated patients undergoing elective surgery in the supine position under general anaesthesia were included. Main exclusion criteria were a history of, or predicted, difficult airway management according to SIAARTI guidelines and absence of written informed consent. INTERVENTIONS: Patients received the LMA-S or Spritztube tracheal cannula to facilitate ventilation of the lungs. MAIN OUTCOME MEASURES: Successful placement (primary outcome), time required for insertion, number of attempts, subjective assessment of ease of insertion, safety and incidence of complications were recorded. RESULTS: One hundred and sixty seven patients were allocated to the LMA-S or Spritztube group, respectively, a total of 334 patients. In the LMA-S group, the device insertion failed in nine patients, compared with none in the Spritztube group (P = 0.002). Spritztube insertion was easy in 100% of cases compared with 94.6% of the cases in the LMA-S group (P = 0.03). The number of attempts was significantly higher with the LMA-S compared with the Spritztube (P = 0.0007), whereas the insertion times were comparable (P = 0.06). Except for the incidence of blood-staining, which was higher in the LMA-S group (P = 0.01), the number of complications was comparable in the two groups. CONCLUSION: The Spritztube was as effective as the LMA-S in maintaining the airway with all patients being successfully ventilated without difficulty. The success rate of achieving a patent airway was comparable between the groups, with a similar occurrence of complications. TRIAL REGISTRATION: NCT03443219.

来源:Eur J Anaesthesiol,查看原文。版权归原作者所有。

引用

  1. De Rosa S, Messina A, Sorbello M, et al. Laryngeal Mask Airway Supreme vs. the Spritztube tracheal cannula in anaesthetised adult patients: A randomised controlled trial. Eur J Anaesthesiol. 2019. PMID: 31644512. doi:10.1097/EJA.0000000000001106

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。